EFTA00490547Set 9
2019-02-059p4,075w
ketamine crossed back into commercial drug
development. In 2009, Johnson & Johnson lured away Husseini
Manji, a prominent NIH researcher worked on the drug, to
run its neuroscience division ... develop ketamine into a new pharmaceutical, but a few years into
his tenure, Manji decided to look into it. This time it would
come in a nasal-spray form ... himself. "We certainly think
that esketamine is working exactly on the circuitry of
depression," Manji says. "Are we homing in exactly on where
suicidal ideation resides?" His former colleagues
https://www.justice.gov/epstein/files/DataSet%209/EFTA00490547.pdf
EFTA00660497Set 9
2012-03-232p413w
Kadish " "Leeds, Jeffrey"
"Leeds, Larry "Lessman, Lance" "Li y,
Lewis" "Lifton, Ja "Lipton, Martin"
, "Manji, Irshad" , "Marcus, Itamar"
EFTA00660497
"M Clifford D." "McCarth
Andrew" "Mceveety, Steve"
"Miller, Morgan" "Miniter, Rich
https://www.justice.gov/epstein/files/DataSet%209/EFTA00660497.pdf